Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice. 2015

Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
1 Organ Transplantation Institute, Medical College, Xiamen University, Xiamen City, Fujian Province, China. 2 Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen City, Fujian Province, China. 3 State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

BACKGROUND T cell-mediated immune rejection is a key barrier to islet transplantation. Preliminary studies have shown that arsenic trioxide (As2O3) can inhibit T cell responses and prolong heart allograft survival. Here, we sought to investigate the possibility of using As2O3 to prolong islet allograft survival in an acute rejection model of Balb/c to C57B/6 mice. METHODS Recipient mice were treated with As2O3 and/or rapamycin after islet allograft transplantation. At day 10 after transplantation, the graft, spleen, lymph nodes, and blood of the recipient mice were recovered for analysis. In vitro, to further examine the mechanism underlying As2O3 protection of islet allografts against T cell-mediated rejection, mixed lymphocyte reaction and apoptosis analyses of T cells were performed. The phosphorylation levels of IκBα and p38 were also evaluated to confirm the proliferation and apoptosis of As2O3-treated T cells. RESULTS We found that As2O3 prolonged islet allograft survival by reducing inflammatory reactions, influencing cytokine synthesis and secretion and T-cell subset proportions, and inhibiting T-cell responses. Furthermore, As2O3 and rapamycin showed a synergistic effect in suppressing islet allotransplant rejection. CONCLUSIONS Arsenic trioxide may prevent allograft rejection by inhibiting T-cell proliferation and inducing T-cell apoptosis.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
March 2018, Cell death & disease,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
September 2015, Transplant immunology,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
January 1997, Transplantation proceedings,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
August 2005, Proceedings of the National Academy of Sciences of the United States of America,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
December 1995, Transplantation proceedings,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
December 1992, Transplantation proceedings,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
May 2012, International immunopharmacology,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
January 2023, Cell transplantation,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
September 2010, Pathology oncology research : POR,
Chang Gao, and Jie Jiang, and Pengfei Ma, and Panpan Cheng, and Yinlong Lian, and Bin Zhao, and Chenglin Li, and Yuanzheng Peng, and Feiyu Wang, and Yingying Lin, and Ning Jin, and Jiali Li, and Lumin Wang, and Qing Li, and Yun Leng, and Junjie Xia, and Zhongquan Qi
July 2011, Transplantation,
Copied contents to your clipboard!